The Federal Trade Commission is requesting more information from Walmart and Vizio on their combination, Vizio said Tuesday. Why it matters: The move could indicate the agency is preparing to ...

, opens new tab regarding their proposed $2.3 billion deal, the smart-TV maker said on Tuesday. U.S. lawmakers have sought for an increased scrutiny from the FTC on many multi-billion dollar deals ...

April 30 (Reuters) - The U.S. Federal Trade Commission has asked for more information from Vizio and Walmart regarding their proposed $2.3 billion deal, the smart-TV maker said on Tuesday.

(Reuters) - The U.S. Federal Trade Commission has asked for more information from Vizio and Walmart regarding their proposed $2.3 billion deal, the smart-TV maker said on Tuesday. U.S. lawmakers ...

(Reuters) - The U.S. Federal Trade Commission has asked for more information from Vizio and Walmart regarding their proposed $2.3 billion deal, the smart-TV maker said on Tuesday. U.S. lawmakers have ...

The Federal Trade Commission (FTC) has kicked off an antitrust inquiry into Walmart Inc.’s proposed acquisition of smart TV company Vizio Inc., which the companies announced in February at a ...

The Federal Trade Commission is taking an in-depth look at the possible antitrust implications of retail giant Walmart Inc.’s deal to buy smart TV maker Vizio Holding Corp. for approximately $2.3 ...

Novo Holdings’ planned acquisition of Catalent is facing another delay. Just weeks after Novo Holdings decided to resubmit its application to the Federal Trade Commission, the agency is seeking ...

, opens new tab, weeks after an application to the regulator was refiled for approval of the deal. Catalent said on Friday the companies were in the process of gathering information to respond to ...

In February, Novo Nordisk agreed to buy Catalent for $16.5 billion. The Federal Trade Commission has since requested more information from the companies as it reviews the deal, The Wall Street ...

(Reuters) -The U.S. FTC has sought more information on Novo Nordisk (CSE:NOVOb) parent's $16.5 billion bid for contract drug manufacturer Catalent, weeks after an application to the regulator was ...